Martin Empting studied chemistry at the TU Darmstadt. He recieved his doctorate under supervision by Harald Kolmar and won the 'Dissertation Prize of the Bottling Family Foundation' for his doctoral thesis. In 2013, he joined the working group of Rolf W. Hartmann (Helmholtz Institute for Pharmaceutical Research Saarland, HIPS) as a PostDoc. Since 2017, he conducts his habilitation at Saarland University and in parallel heads his own individual research group, while also leading the “PqsR Inverse Agonists” project at HIPS. The latter is focused on lead generation and lead optimization of Quorum Sensing Inhibitors (QSI) for the adjunctive therapy of chronic lung infections by Pseudomonas aeruginosa. His research interests are dedicated to the medicinal chemistry-driven exploration of underexploited targets to tackle bacterial and viral infections. Among those are translational and post-translational regulators as well as macromolecule-macromolecule interactions.